# Biological Therapy in Treating Patients With Primary or Advanced Glioma

> **NCT00003067** · PHASE2 · SUSPENDED · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** lymphokine-activated killer cells

## Key facts

- **NCT ID:** NCT00003067
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003067, "Biological Therapy in Treating Patients With Primary or Advanced Glioma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00003067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*